[Escape from apoptosis in liver cancer cells].
Sasaki
Y
Y
Molecular Therapeutics, Osaka University Graduate School of Medicine.
D000818:Animals; D017209:Apoptosis; D020169:Caspases / Q000378:metabolism; D053222:Fas Ligand Protein; D016158:Genes, p53; D016174:Hepacivirus; D006515:Hepatitis B virus; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D019476:Insect Proteins / Q000502:physiology; D008113:Liver Neoplasms / Q000473:pathology; D008562:Membrane Glycoproteins; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000502:physiology; D015398:Signal Transduction; D013602:T-Lymphocytes, Cytotoxic
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D051034:Inhibitor of Apoptosis Proteins; D019476:Insect Proteins; D008562:Membrane Glycoproteins; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D019869:Phosphatidylinositol 3-Kinases; D020169:Caspases